Blockchain Registration Transaction Record

Biotech Company Glafabra Therapeutics Collaborates with University of Utah for Fabry Disease Clinical Investigation

Glafabra Therapeutics partners with University of Utah for groundbreaking Fabry disease clinical investigation. Collaboration aims to advance development of new treatment for rare genetic disorder, addressing unmet medical need.

Biotech Company Glafabra Therapeutics Collaborates with University of Utah for Fabry Disease Clinical Investigation

This news highlights a significant collaboration between a leading biotechnology company and a renowned research institution to advance the development of a new treatment for a rare genetic disorder. The partnership has the potential to bring innovative therapies to patients suffering from Fabry disease, addressing an unmet medical need in the field of rare diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x4dc9924f9818e7694cc9adc2e2dc2d4e774d009f323b0fd5693184f5c2afe776
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintjazzu6ga-750195bbb33dba6c350b959d3ab24596